FEB 04, 2016 06:00 AM PST

Improving methodological quality of animals experiments - are we doing all we can?

C.E. CREDITS: RACE
Speakers
  • Post-Doc Researcher, i3S (Instituto de Investigação e Inovação em Saúde)
    Biography
      Nuno Franco is a biologist and postdoctoral researcher at the i3S' Laboratory Animal Science group, and an external advisor for LAS at the Universdity of Lisbon's IMM.
      His research focuses on laboratory animal welfare, along with ethical, legal, social and scientific issues in animal research. His research interests also include translational science, science communication and education. He is currently setting up a national network of animal welfare bodies in Portugal.

    Abstract:

    Public, legal & ethical acceptability of animal research not only warrants respect for animal welfare & the 3Rs, but also that the perceived benefits can outweigh the pain, discomfort or distress endured by animals. However, there is growing evidence that promising results in animal tests often fail to translate in clinical trials. This has led animal rights activists to increasingly challenge animal experiments on scientific grounds, questioning their validity to inform on human disease.

    It has been shown, that preclinical findings suggesting an effect for candidate drugs are often false-positives in the first place, as a consequence of unaccounted biases from underpowered, non-randomized, non-blinded experiments. These have led to unreliable – and thus irreproducible – results in preclinical research, a problem further exacerbated by publication bias towards “positive findings”, which skews the available evidence on drug efficacy.

    The ‘noise’ in experimental outcomes from poor methodological standards prevents an adequate assessment of the true informative value of current animal models. It also leads to millions being wasted to test drugs in humans, without convincing evidence of their effectiveness in animals. More importantly, by being based on unreliable data from sub-standard animal studies, these trials fail to provide real hope to the patients enrolled.

    This presentation will cover common sources of bias in animal studies, and discuss whether the scientific community has succeeded in improving the planning, execution and reporting of animal studies. The importance of making preclinical results more reliable & reproducible as a condition before moving to clinical trials will be also addressed.

    Learning Objectives:

    • Understanding that reproducibility in preclinical research must precede translatability.
    • Acknowledging the responsibility of every scientist – as researchers, mentors, reviewers or editors – in promoting higher standards in animal research.

    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    Loading Comments...